Since January 2010, HTA organizations across the globe have issued nearly 1,000 CE reports. Yet just 5% of this U.S.-based research and 9% of research outside the U.S. address four high-burden conditions: non-small cell lung cancer, rheumatoid arthritis, multiple sclerosis and hepatitis C.